Galantos Pharma

About:

Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.

Website: http://www.galantos.com

Top Investors: KfW, HTGF | High-Tech Gruenderfonds, Rheinland-Pfalz Fonds, VRP Rhineland Palatinate Fund

Description:

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer's and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer's dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.